Identification of a novel fentanyl analogue: p-hydroxy-butyrylfentanyl.

Clicks: 271
ID: 51814
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The use of new psychoactive substances (NPS) has become an important worldwide concern. In particular the use of highly potent fentanyl analogues forms a great health threat to users. In this publication, we detail the characterization of a new fentanyl analogue N-(4-hydroxyphenyl)-N-(1-phenethylpiperidin-4-yl)-butyramide (p-hydroxy-butyrylfentanyl) encountered in drug casework in the Netherlands. Characterization was performed using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared (FTIR) spectroscopy and X-ray fluorescence (XRF).
Reference Key
oldenhof2019identificationdrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oldenhof, Sander;Ten Pierick, Angela;Bruinsma, Jildert;Eustace, Stephen;Hulshof, Janneke;van den Berg, Jorrit;Hoitink, Marnix;
Journal drug testing and analysis
Year 2019
DOI
10.1002/dta.2695
URL
Keywords
identification fentanyl new psychoactive substance nps

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.